6 Recruiting Advanced Malignant Neoplasm Phase 2 Clinical Trials
Active phase 2 studies for advanced malignant neoplasm enrolling across the USA. Verify eligibility and contact site coordinators.
All Advanced Malignant Neoplasm studiesPhase 2 Studies for Advanced Malignant Neoplasm
🔵 Active, Not Recruiting Phase2 / Phase3
Physical Activity and Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Advanced Cancer
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 / Phase3
Haloperidol With or Without Chlorpromazine in Treating Delirium in Patients With Advanced, Metastatic, or Recurrent Cancer
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2
Talazoparib in Treating Patients With Recurrent, Refractory, Advanced, or Metastatic Cancers and Alterations in the BRCA Genes
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 / Phase2
Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor
📍 Stanford Cancer Institute — Palo Alto, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 / Phase2
First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
📍 University of California, Los Angles (UCLA) Department of Medicine - Hematology/Oncology — Los Angeles, California
View Study & Checklist ➔